Is overexpression of Pim-1 associated with poor prognosis in patients with esophageal squamous cell carcinoma?
These findings demonstrate that Pim-1 may be used as molecular marker for predicting the prognosis of patients with ESCC.
These data indicate that the protective effect of HSP20 in vitro is primarily due to reduced necrotic and apoptotic death of cardiomyocytes, possibly via the protein kinase C/mitochondrial K+ATP pathway.